Douglas Fisher

Chief Business Officer at Sera Prognostics

Dr. Fisher is a former partner of InterWest Partners, LLC, and served on Sera’s Board of Directors since the company’s Series A funding in November 2011. He joined Sera as its business and strategy development executive in January 2015 and continues to serve as an Executive-in-Residence at InterWest Partners. Dr. Fisher has focused on biopharmaceutical, diagnostic, and medical device investments throughout his career, working in venture capital, consulting, and pharmaceutical industries. He received his M.D. and M.B.A. from the School of Medicine and the Wharton School, respectively, at the University of Pennsylvania.


  • Chief Business Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.